- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04801680
Mpact 3D Metal Cup PMS
A Multicentric, Prospective Clinical Survey on Long Term Performance of an Acetabular Component in Primary Total Hip Arthroplasty
Cementless fixation, with or without screw augmentation, has evolved during the past few decades as the preferred method for acetabular reconstruction. Although major improvements have been recorded with regard to clinical outcomes and survivorship, acetabular component loosening remains among the most common causes of failure and revision. Patient age, poor bone quality and conditions, such as osteonecrosis and dysplasia, have been observed to influence negatively long-term clinical results.
Initial stability is fundamental for survivorship of cementless cups. Prerequisites to achieve durable cementless cup fixation are close contact with viable native bone, primary mechanical stability and secondary bone integration. Press-fit techniques provide optimal conditions for bone ingrowth and fixation but research focused on cup material in order to improve primary stability. Pore size, bone-implant apposition, and material properties all influence bone ingrowth and long-term stability.
Biological ingrowth surfaces have become a standard prosthetic element in reconstructive hip surgery. A material's properties, three-dimensional architecture, and surface texture all play integral parts in its biological performance. Trabecular metal is an important new biomaterial that has been introduced to enhance the potential of biological ingrowth as well as provide a structural scaffold in cases of severe bone deficit. The continuity between the porous and solid parts has been specifically developed to overcome the limitations of the traditional porous coatings. In fact, the absence of an interface between the trabecular structure and the bulk material provides greater structural solidity and thus higher resistance to detachment and corrosion. Initial clinical applications have focused on bone restoration in tumor and salvage cases and in primary and revision reconstructive cases where the increased biological fixation would be of clinical benefit. However the bone ingrowth potential and mechanical integrity of this material offer exciting options for orthopedic reconstructive surgeons such as difficult THA cases, such as patients with high demands, subjects affected by severe hip conditions (i.e. osteonecrosis, dysplasia) or with extremely poor bone quality. Medacta Mpact 3D Metal cup, is an acetabular cup realized using the EBM (Electron Beam Melting) powder technology; this production method offers a high friction and scratch-fit feel for the initial stability, without the need of any additional coating. Moreover the 3D Metal structure creates a favorable environment for bone thus providing secondary fixation.
The aim of this study is to evaluate the long term clinical and radiological performance of MPact 3D Metal acetabular component.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Luigi Zagra, Dr
- Phone Number: 00390266214834
- Email: luigi.zagra@fastwebnet.it
Study Locations
-
-
MI
-
Milan, MI, Italy, 20161
- Recruiting
- IRRCCS Istituto Ortopedico Galeazzi
-
Contact:
- Rocco D'Appolito
- Phone Number: +39 02 662141
- Email: roccodapolito@hotmail.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Those suffering from hip primary arthrosis, post-traumatic arthrosis, hip dysplasia or avascular necrosis of femoral head, rheumatic arthrosis
- Those aged between 18 and 75 years old at the surgery time
- those suitable to undergo to a primary total hip arthroplasty for whom the Mpact 3D Metal cup will be implanted (according to the label indication/contraindications)
- Patients who are willing and able to provide written informed consent for participation in the study. Written informed consent must be obtained prior to patient's surgery
Exclusion Criteria:
- Those with acute or chronic infection
- Those whose mental conditions may compromise their ability to provide informed consent to study participation, ability to complete questionnaires or complete 10-year follow-ups.
- Those suffered by severe deformation, at the discretion of surgeon
- Those suffered by osteoporosis
- Those with metabolic disorders that may involve bone metabolism for which cementless implants are contraindicated
- Those suffered by muscular atrophy or neuromuscular disease
- Those allergic to medical device material previewed for the surgery
- Those unable to give their consent to participate in the study or who do not want to participate
- Those whose functional recovery is compromised by
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Mpact 3d metal
Subjects, among those whose clinical condition makes them eligible for a primary total hip arthroplasty, will be invited to participate to the study during preoperative visit.
The
|
Subjects, among those whose clinical condition makes them eligible for a primary total hip arthroplasty, will be invited to participate to the study during preoperative visit.
They'll receive the Mpact 3D metal cup device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
long term performance
Time Frame: 10 years
|
Device survival will be assessed by Kaplan Meier curve
|
10 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical performance
Time Frame: 3 months, 1, 5, 7 and 10 years after surgery
|
Harris Hip Score collected during preoperative and follow-up visits.
Harris Hip score scale correspond to 0-100 points.
Results can be interpreted with the following: <70 = poor result; 70-80 = fair, 80-90 = good, and 90-100 = excellent.
|
3 months, 1, 5, 7 and 10 years after surgery
|
Radiological performance
Time Frame: 3 months, 1, 5, 7 and 10 years after surgery
|
standard x-ray exam performed preoperatively and postoperatively before discharge from hospital and during follow-up visits
|
3 months, 1, 5, 7 and 10 years after surgery
|
Hip physical function after surgery
Time Frame: 3 months and 1, 5, 7 and 10 years after surgery
|
HOOS-PS score collected during preoperative visit and follow-up visit.
HOOS PS scale correspond to 100 (no difficulty) to 0 (extreme difficulty) scale.
|
3 months and 1, 5, 7 and 10 years after surgery
|
Rate of complications
Time Frame: up to 10 years after surgery
|
collection of adverse events
|
up to 10 years after surgery
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- P01.023.01
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Total Hip Arthroplasty
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
DePuy OrthopaedicsJohnson & Johnson Health and Wellness Solutions, Inc.TerminatedTotal Knee Arthroplasty; Total Hip ArthroplastyUnited States
-
National Taiwan University HospitalUnknownTotal Hip Replacement | Total Hip ArthroplastyTaiwan
-
Northern Orthopaedic Division, DenmarkCompletedTotal Knee Arthroplasty | Total Hip ArthroplastyDenmark
-
Ortho Development CorporationOregon Health and Science UniversityEnrolling by invitationTotal Hip Replacement | Total Hip ArthroplastyUnited States
-
James A. KeeneyRecruitingPrimary Total Hip Arthroplasty | Primary Total Knee ArthroplastyUnited States
-
Musgrave Park HospitalBelfast Health and Social Care Trust; Queen's University, Belfast; Belfast Arthroplasty...CompletedTotal Hip Replacement | Total Hip Arthroplasty | THA | THRUnited Kingdom
-
Permedica spaNot yet recruitingTotal Hip ArthroplastyItaly
-
ExactechNot yet recruitingHip Arthroplasty, Total
-
Mauro CrestaniRecruitingTotal Hip ArthroplastyItaly
Clinical Trials on Mpact 3D metal cup
-
Medacta International SARecruiting
-
Medacta USACompletedHip OsteoarthritisUnited States
-
Medacta International SAActive, not recruiting
-
The Cleveland ClinicZimmer BiometCompletedRevision, JointUnited States
-
Medacta USAActive, not recruitingOsteoarthritis, HipUnited States
-
Sahlgrenska University Hospital, SwedenCompletedProsthesis LooseningSweden
-
Nova Scotia Health AuthorityUniversity Health Network, TorontoTerminatedOsteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Ankylosing Spondylitis | Post-traumatic; Arthrosis | Congenital Dysplasia of the Hip | Injury of Hip and Thigh
-
Anderson Orthopaedic Research InstituteDePuy OrthopaedicsCompleted
-
Chinese University of Hong KongCompletedRandomized Controlled Trial | OsteotomyHong Kong
-
Southwest Hospital, ChinaUnknown